2014 BIO Asia Participating Companies

  • Recommend
  • Tweet
  • Print
  • Email

Western 


Ab-Biotics SA
AbbVie
AcelRx Pharmaceuticals, Inc.
Actavis, Inc.
Activaero GmbH
Acucela, Inc.
Adamant Biomedical Investments AG
Aeterna Zentaris Gmbh
Aguettant Laboratoire
Amarin Pharma, Inc.
Anacor Pharmaceuticals, Inc.
Antabio
Ardelyx, Inc.
ArmaGen Technologies
AstraZeneca
Athersys, Inc.
Bayer HealthCare
BioCentury Publications, Inc.
Bioinvent International AB
BioMedTracker
Biontech AG
Biovest International, Inc.
Burrill & Company
Curis, Inc.
Comentis, Inc.
Comprehensive Biomarker Center Gmbh
Debiopharm SA
Dicerna Pharmaceuticals, Inc.
Elanco
Eli Lilly and Company
EMD Serono, Inc.
Fabpharma
Fairjourney Lda
Fiveprime Therapeutics, Inc.
Greenblum & Bernstein, plc
Heat Biologics, Inc.
Innovus Pharmaceuticals, Inc.
Invest In Skane AB
Invion Group
Lacer, SA
Latham & Watkins, LLP
Lazard
Liberi Life Sciences Consultancy BV
LTS Lohmann Therapie-Systeme AG
Marina Biotech, Inc.
The Medicines Company
Medimetriks Pharmaceuticals, Inc.
Menarini
Morrison & Foerster, LLP
Novo Nordisk
Novozymes
Opsona Therapeutics, Ltd.
Organovo, Inc.
PCI Biotech
Peregrine Pharmaceuticals, Inc.
Pfizer, Inc.
Pharmasia News
Phosplatin Therapeutics
Polynoma LLC
Portola Pharmaceuticals, Inc.
Protein Sciences Corporation
Proteon Therapeutics
Sanofi
SCRIP Intelligence
SIMI Law Group
Sinoveda Canada, Inc.
SRI International
Syndax Pharmaceuticals, Inc.
Tanaka International, LLC
Therapeuticsmd
Thomson Reuters
Tigenix Nv
Torreya Partners, LLC
Trevena, Inc.
Vaccine and Infectious Disease Organization
Vifor Pharma
Wave Life Sciences

 

Asian


AI Bios Co., Ltd.
Allergan Singapore Pte Ltd.
Asahi Kasei Corporation
ASLAN Pharmaceuticals Pte Ltd.
ASTEC
Astellas Pharma, Inc.
AstraZeneca K.K.
Baxter 
Beijing Fogangren Bio-Pharm Tech, Co., Ltd.
Chugai Pharmaceutical Co., Ltd.
Curadev Pharma Pvt, Ltd.
Daiichi Sankyo, Inc.
Dong-A ST
Dr.Reddy's Laboratories, Ltd.
Eddingpharm
Fresenius Kabi Asia Pacific, Ltd.
GBI Health
Generon Corporation, Ltd.
GlaxoSmithKline
Global Health Innovative Technology Fund (GHIT Fund)
Golden Biotechnology Corporation
GVK Biosciences Private, Ltd.
Healios K.K.
Hua Medicine
ICS Convention Design, Inc.
Ildong Pharmaceutical Co., Ltd.  
Integrated Development Associates Co., Ltd
JCR Pharmaceuticals Co., Ltd.
Jeil Pharmaceutical
Johnson & Johnson (Asia Pacific)
JT Pharma
Kissei Pharmaceutical Co., Ltd.
Krishna & Saurastri Associates
Lingmed Limited
Lundbeck Research China
MEDRx Co., Ltd.
Meiji Seika Pharma
Merck Serono SA
Mergermarket
Mitsubishi Tanabe Pharma Corporation
Mitsui Chemicals Inc.
Mizuho Financial Group
Mochida Pharmaceutical Co., Ltd.
MSD K.K.
Nihon Servier Company, Ltd.
Nippon Kayaku Co., Ltd.
Novartis Asia Pacific Pharmaceuticals Pte, Ltd.
Ono Pharmaceutical Co., Ltd. 
Peking University Health Science Center
Pluristem Therapeutics, Inc.
PRISM Pharma Co., Ltd.
ReqMed Company, Ltd.
Rohto Pharmaceutical Co., Ltd.
Sanofi Aventis Singapore Pte, Ltd.
Sanwa Kagaku Kenkyusho Co., Ltd.
Sosei Co., Ltd.
TaiGen Biotechnology Co., Ltd.
Taiho Pharmaceutical Co., Ltd. 
Taiwan Liposome Company Co., Ltd. (TLC)
Takeda Pharmaceutical Co., Ltd.
Tech Manage Corp.
Teva Pharmaceutical Industries, Ltd.
Tokyo Stock Exchange, Inc.
University of Tokyo
Worldiscoveries Asia, Ltd.

 

*As of 4/1/2014